SCHEMBL25150405

SCHEMBL25150405

Cc1ccn2nc(-c3ccc(F)cc3F)c(C(C)C)c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 1/20 0.41
▸ HTR6 P50406 2/20 0.38
▸ ADORA2A P29274 4/20 0.37
▸ ADORA2B P29275 3/20 0.37
▸ ADORA1 P30542 2/20 0.37
▸ MAP4K4 O95819 3/20 0.37
▸ MAPK9 P45984 3/20 0.37
▸ CSNK1D P48730 3/20 0.37
▸ MINK1 Q8N4C8 3/20 0.37
▸ PRKD2 Q9BZL6 3/20 0.37
▸ PRKD3 O94806 2/20 0.37
▸ GRM5 P41594 1/20 0.35
▸ KCNH2 Q12809 2/20 0.35
▸ DPP4 P27487 1/20 0.35
▸ FAP Q12884 1/20 0.35
▸ DPP8 Q6V1X1 1/20 0.35
▸ EGFR P00533 1/20 0.34
▸ F2RL3 Q96RI0 1/20 0.34
▸ GCGR P47871 1/20 0.34
▸ MAPK14 Q16539 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23023590 0.84 PTGS2 (0.44) PTGS2HTR6ADORA2AADORA2BADORA1
SCHEMBL23023565 0.78 PTGS2 (0.42) PTGS2HTR6ADORA2AADORA2BMAPK9
SCHEMBL23023679 0.74 SLC34A1 (0.43) PTGS2HTR6GRM5SLC34A1
SCHEMBL21526649 0.69 ALDH1A1 (0.41) PTGS2HTR6ADORA2AADORA1
SCHEMBL25150620 0.69 MAOB (0.41) —
SCHEMBL23023602 0.68 HTR6 (0.41) PTGS2HTR6ADORA2AADORA2BADORA1
SCHEMBL9752941 0.67 ALDH1A1 (0.35) PTGS2ADORA2AADORA2BADORA1MAP4K4
SCHEMBL9753098 0.67 GCGR (0.40) ADORA2AADORA2BADORA1MAP4K4MAPK9
SCHEMBL23023571 0.66 ADORA2A (0.40) PTGS2HTR6ADORA2AADORA2BADORA1
SCHEMBL23023705 0.66 MAP4K4 (0.41) ADORA2AADORA2BADORA1MAP4K4MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634425-B2 Pharmaceutical compounds PFIZER INC. (US) 2023-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11634425-B2 Pharmaceutical compounds GABRA6, CHRNA6, CNR1 PTGS2 3812/4885HTR6 169/4885ADORA2A 989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback